![Katherine J. Flagg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katherine J. Flagg
Direktor/Vorstandsmitglied bei
ACOUSORT AB
Profil
Katherine J.
Flagg is currently an Independent Director at AcouSort AB since 2021.
Former positions include Director-Business Unit at Standard BioTools, Inc., Principal at IGENE Biotechnology, Inc., Principal at BioVeris Corp., Vice President-Global Sales & US Operations at Gyros AB from 2011 to 2015, Principal at ProterixBio, Inc., Vice President-Business Development at Rapid Micro Biosystems, Inc., Principal at Pharmacia Biotech AB, Principal at Igenta.com, Vice President-Sales at ForteBio, Inc., and Senior Vice President-Americas at Gyros Protein Technologies AB from 2019 to 2020.
Education includes undergraduate studies at Douglass Residential College.
Aktive Positionen von Katherine J. Flagg
| Unternehmen | Position | Beginn |
|---|---|---|
| ACOUSORT AB | Direktor/Vorstandsmitglied | 01.12.2021 |
Ehemalige bekannte Positionen von Katherine J. Flagg
| Unternehmen | Position | Ende |
|---|---|---|
Gyros Protein Technologies AB
 Gyros Protein Technologies AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays | Corporate Officer/Principal | 01.12.2020 |
ProterixBio, Inc.
 ProterixBio, Inc. Medical SpecialtiesHealth Technology Supplies novel protein measurement technology | Corporate Officer/Principal | - |
| STANDARD BIOTOOLS INC. | Corporate Officer/Principal | - |
Pharmacia Biotech AB
 Pharmacia Biotech AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Corporate Officer/Principal | - |
| IGENE BIOTECHNOLOGY, INC. | Corporate Officer/Principal | - |
Ausbildung von Katherine J. Flagg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
IGENE Biotechnology, Inc.
 IGENE Biotechnology, Inc. Chemicals: AgriculturalProcess Industries Develops, markets and manufactures ingredients for human and animal nutrition | Process Industries |
Standard BioTools, Inc.
 Standard BioTools, Inc. Medical SpecialtiesHealth Technology Manufactures and markets innovative technologies and tools for life sciences research | Health Technology |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Health Technology |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays | Health Technology |
ProterixBio, Inc.
ProterixBio, Inc. Medical SpecialtiesHealth Technology Supplies novel protein measurement technology | Health Technology |
Rapid Micro Biosystems, Inc.
 Rapid Micro Biosystems, Inc. Industrial MachineryProducer Manufacturing Develops automation solutions for pharmaceutical and healthcare manufacturing products | Producer Manufacturing |
Pharmacia Biotech AB
Pharmacia Biotech AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Igenta.com
 Igenta.com Internet Software/ServicesTechnology Services Provides Internet search services for researchers and publishers | Technology Services |
ForteBio, Inc.
 ForteBio, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets biomolecular analysis products | Health Technology |
AcouSort AB
 AcouSort AB Medical DistributorsDistribution Services Develops methods and devices for isolation of cells | Distribution Services |
Douglass Residential College
 Douglass Residential College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gyros Protein Technologies AB
Gyros Protein Technologies AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays | Health Technology |
